Line 135: | Line 135: | ||
<h2>Problems: </h2> | <h2>Problems: </h2> | ||
− | <h3> | + | <h3>Awareness for antibiotic resistance is lacking</h3> |
<p>There is a worldwide ignorance on the subject of microbial resistance to antibiotics and Costa Rica is not the exception. Globally, the main cause of this problem is the misuse of antibiotics, leading to the survival of some resistant bacteria, able to spread again. Also, the bad waste management of these drugs contributes to increase resistant bacteria. This bacteria can later transfer their resistance to human microbiota (van Rijn et al., 2019). </p> | <p>There is a worldwide ignorance on the subject of microbial resistance to antibiotics and Costa Rica is not the exception. Globally, the main cause of this problem is the misuse of antibiotics, leading to the survival of some resistant bacteria, able to spread again. Also, the bad waste management of these drugs contributes to increase resistant bacteria. This bacteria can later transfer their resistance to human microbiota (van Rijn et al., 2019). </p> | ||
Line 148: | Line 148: | ||
+ | <h2>References</h2> | ||
+ | <p> | ||
+ | Jackson, N., Czaplewski, L., & Piddock, L. J. (2018). Discovery and development of new antibacterial drugs: learning from experience?. Journal of Antimicrobial Chemotherapy, 73(6), 1452-1459. | ||
+ | O’Neill, J. (2014). Antimicrobial resistance. Tackling a Crisis for the Health and Wealth of Nations. | ||
+ | |||
+ | Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., ... & Ouellette, M. (2018). Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infectious Diseases, 18(3), 318-327. | ||
+ | |||
+ | van Rijn, M., Haverkate, M., Achterberg, P., & Timen, A. (2019). The public uptake of information about antibiotic resistance in the Netherlands. Public Understanding of Science, 28(4), 486-503. | ||
+ | </p> | ||
</div> | </div> |
Revision as of 21:03, 17 October 2019